Terms ending in 2031
Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,029,377 | Platelet-Activating Factor Receptor Antagonists In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,278,304 | Substituted 4-Hydroxypyrimidine-5-Carboxamides In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,394,819 | Indole Derivatives as CRTH2 Receptor Antagonists In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,603,998 | Novel Modulators of Cell Cycle Checkpoints and Their Use in Combination with Checkpoint Kinase Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,513,234 | HIV Integrase Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US D777,907 | Medical Injector Pen In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US D777,908 | Medical Injector Device In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,192,746 | 15-Valent Pneumococcal Polysaccharide-Protein Conjugate Vaccine Composition In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,394,969 | Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,796,452 | Preparation of Lamivudine Form I In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| 143 more term ends in 2031 · Pro | |||||
10 of 153 patents shown. Soonest term end first, then patent number.
Pro members see all 153.
109 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.